Guillain-Barre Syndrome Clinical Trial
Official title:
Comparison of Effects of Proprioceptive Neuromuscular Training on Sensory Versus Motor Function in Patients With Guillain Barre Syndrome
Verified date | July 2023 |
Source | Riphah International University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to determine the effects of Proprioceptive Neuromuscular Training on Sensory versus Motor Function in patients presenting with Guillain Barre Syndrome.
Status | Completed |
Enrollment | 26 |
Est. completion date | February 28, 2023 |
Est. primary completion date | February 28, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 10 Years to 25 Years |
Eligibility | Inclusion Criteria: 1. Diagnosed with Guillain Barre Syndrome already taking treatments 2. Inflammatory Demyelinating Guillain Barre Syndrome patients 3. Acute motor sensory axonal neuropathy 4. Guillain Barre Syndrome patients in the subacute phase 5. Guillain Barre Syndrome patients with impaired proprioception 6. Patients with Glasgow Coma Scale above 12 Exclusion Criteria: 1. Other Guillain Barre Syndrome types 2. Spinal cord injury 3. Traumatic neuritis 4. Not Fulfilling Above Criteria Of Age |
Country | Name | City | State |
---|---|---|---|
Pakistan | psrd (pakistan Society for the rehabilitation of the disabled) | Lahore | Punjab |
Lead Sponsor | Collaborator |
---|---|
Riphah International University |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Berg Balance Scale | The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to completed. | 12th Week | |
Primary | Time up and go test | It is used to determine fall risk and measure the progress of balance, sit to stand and walking.It is Simple screening test that is a sensitive and specific measure of probability for falls among older adults. | 12th Week | |
Primary | One leg stance test | The Single leg Stance Test is used to assess static postural and balance control. Balance assessments are a valuable clinical tool for monitoring neurological and musculoskeletal status as well as for managing fall risk. | 12th Week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04053452 -
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
|
N/A | |
Recruiting |
NCT02582853 -
sCD163 as a Potential Biomarker in Guillain- Barré Syndrome
|
N/A | |
Completed |
NCT00056810 -
Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
|
Phase 2 | |
Completed |
NCT05104762 -
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
|
Phase 2/Phase 3 | |
Recruiting |
NCT05630313 -
Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
|
||
Recruiting |
NCT03801135 -
Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation
|
N/A | |
Active, not recruiting |
NCT01655394 -
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
|
N/A | |
Completed |
NCT04927598 -
Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
|
||
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 | |
Not yet recruiting |
NCT04092140 -
Neuromuscular Ultrasound in Correlation to Neurophysiological Findings
|
||
Not yet recruiting |
NCT04550611 -
Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
|
N/A | |
Withdrawn |
NCT03268304 -
Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments
|
||
Not yet recruiting |
NCT05701189 -
Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome
|
Phase 2 | |
Withdrawn |
NCT02459808 -
Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome
|
N/A | |
Completed |
NCT04752566 -
A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
|
Phase 3 | |
Completed |
NCT05292690 -
An Assistive Powered Wheelchair: Stage 2 Trial
|
||
Not yet recruiting |
NCT06300359 -
Prognostic Indicators of Gullian-Barre Syndrome
|
||
Completed |
NCT00575653 -
Safety Study of GBS Following Menactra Meningococcal Vaccination
|
N/A | |
Not yet recruiting |
NCT05114941 -
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
|
N/A | |
Completed |
NCT05945784 -
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
|